Interexpert Agreement on Adverse Events’ Evaluation
Study measures the differing judgment levels between clinical investigators and drug safety experts.
Drug safety surveillance, a core focus of clinical trials, can be influenced by subjective judgement, as this analysis of differing expert assessments of adverse drug reactions-and the reasons why-shows.
Decline of Trials in CEE: Fluctuation or Trend?
Examining why newly registered trials have fallen in Central and Eastern Europe, relative to other regions.
Death Waivers an Incomplete Picture of Drug Safety
Examining the practical significance of reporting patient deaths due to main disease progression.
Death Waivers Draw an Incomplete Picture of Drug Safety